# ISMRM & ISMRT Announce Early Registration for 2027 Annual Meeting & Exhibition in Vancouver

- Published: 2026-11-19

- Press release: [Read the release](<https://www.einpresswire.com/article/957550012/ismrm-ismrt-announce-early-registration-for-2027-annual-meeting-exhibition-in-vancouver?ref=rss&code=S-lrx9ElWVT94da9>)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/ismrm-ismrt-announce-early-registration-for-2027-annual-meeting-exhibition-in-vancouver/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

[![ISMRM & ISMRT Logo 2026](https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/30465692-ismrm-ismrt-logo-2026-300x121.png)](https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/30465692-ismrm-ismrt-logo-2026-3750x1520.png#3750x1520)

*Global MR community invited to register early and plan ahead for international travel requirements*

CONCORD, CA, UNITED STATES, November 19, 2026 /[EINPresswire.com](https://www.einpresswire.com/)/ -- The International Society for Magnetic Resonance in Medicine (ISMRM) and the International Society for MR Radiographers & Technologists (ISMRT) announce that early registration is now open for the 2027 ISMRM & ISMRT Annual Meeting & Exhibition, taking place 08-13 May 2027 in Vancouver, BC, Canada.  
  
Under the theme Development in Every Dimension, the Annual Meeting will bring together magnetic resonance (MR) professionals from around the world for six days of scientific discovery, education, technological innovation, and global collaboration.  
  
EARLY REGISTRATION NOW OPEN. Attendees are encouraged to register early to take advantage of discounted registration rates and begin planning their Vancouver experience.  
  
The 2027 meeting offers educational and scientific programming tailored to the diverse needs of the global MR community:  
\- ISMRM: Six days of scientific exchange and education covering MR research, clinical applications, physics, engineering, technology, and innovation.  
\- ISMRT: Three days of focused clinical education for MR radiographers and technologists, emphasizing patient care, practical applications, and professional development.  
\- Technical Exhibition: Opportunities to explore emerging MR technologies, products, and developments from industry leaders.  
\- Global Networking: Opportunities to connect with colleagues, exchange knowledge, and strengthen international collaborations.  
  
Discounted early registration rates are available through 07 April 2027.  
[Review the Meeting Information and Registration](http://www.ismrm.org/27m/).  
  
TRAVELING TO VANCOUVER? CHECK ENTRY REQUIREMENTS AND PLAN AHEAD! ISMRM & ISMRT encourage all attendees traveling to Canada to review entry requirements and make travel arrangements well in advance.  
  
Recommended Registration Date for Attendees Requiring a Canadian Visitor Visa: 08 January 2027  
Canadian visitor visa processing can take a minimum of four months or longer in some cases, depending on the applicant's country and individual circumstances.  
  
Attendees requiring a Canadian visitor visa are strongly encouraged to register as early as possible, preferably by 08 January 2027, to allow sufficient time for visa processing and travel preparations.  
  
Additional information about Canadian entry requirements, visa invitation letters, and the application process is available on the Society's dedicated visa information page. [Preview the Visa Information and Requirements](http://www.ismrm.org/27m/visa/).  
  
INTERESTED IN EXHIBITING IN VANCOUVER? Connect with the global MR community at the 2027 ISMRM & ISMRT Annual Meeting & Exhibition. Organizations interested in showcasing their products, technologies, and innovations are encouraged to explore exhibition opportunities. [Review the 2027 Exhibitor Prospectus](http://www.ismrm.org/27m/prospectus/).  
  
CONNECT WITH ISMRM & ISMRT AT RSNA 2026. Attending RSNA 2026 in Chicago? Visit ISMRM & ISMRT at Booth #1205 to learn more about the 2027 Annual Meeting & Exhibition in Vancouver. Our team will be available to answer questions about registration, meeting programming, and opportunities to participate.  
We look forward to connecting with members of the global MR community in Chicago!  
  
ABOUT ISMRM & ISMRT. The International Society for Magnetic Resonance in Medicine (ISMRM) and the International Society for MR Radiographers & Technologists (ISMRT) are dedicated to advancing magnetic resonance through research, education, clinical practice, and global collaboration. Together, they support an international community of MR professionals committed to scientific innovation and improved patient care. Find out more [https://www.ismrm.org/](https://www.ismrm.org/).

Parshy Phillips  
ISMRM & ISMRT  
+1 510-841-1899  
Visit us on social media:  
[LinkedIn](https://www.linkedin.com/company/ismrm/home/)  
[Bluesky](https://bsky.app/profile/ismrm.bsky.social)  
[Instagram](https://www.instagram.com/ismrm_ismrt/)  
[Facebook](https://www.facebook.com/ISMRM/)  
[YouTube](https://www.youtube.com/ISMRM)  
[X](https://x.com/ISMRM)

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

![](https://www.einpresswire.com/tracking/article.gif?aid=957550012&section=einpresswire&a=Norg3bOhbNb-v7-Y&r=Ohkp76qG8AiWTQ6s&i=ZjfZCQe69wHO4kaq)

## Related

- [Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://healthcarenews.io/news/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md)
- [Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease](https://healthcarenews.io/news/press-release-sanofis-infilbray-approved-in-the-us-as-the-first-medicine-to-treat-neurolog.md)
- [Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program](https://healthcarenews.io/news/palvella-therapeutics-to-host-webcast-to-introduce-new-qtorin-program.md)
- [Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company](https://healthcarenews.io/news/teva-announces-r-d-leadership-transition-eric-hughes-to-depart-the-company.md)
